Journal
NUCLEIC ACIDS RESEARCH
Volume 50, Issue 9, Pages -Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkac030
Keywords
-
Categories
Funding
- National Institutes of Health [R21AG060459, R01AG061127, R01AG062634, R01CA158472, R01CA200987]
- National Institute on Aging [P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152]
- Illinois Department of Public Health
- Translational Genomics Research Institute
Ask authors/readers for more resources
MethReg is an R/Bioconductor package that analyzes DNA methylation and gene expression data, along with transcription factor binding information, to evaluate and annotate CpG sites with high regulatory potential. The software plays an important role in studying the regulatory roles of DNA methylation in complex diseases.
Epigenome-wide association studies often detect many differentially methylated sites, and many are located in distal regulatory regions. To further prioritize these significant sites, there is a critical need to better understand the functional impact of CpG methylation. Recent studies demonstrated that CpG methylation-dependent transcriptional regulation is a widespread phenomenon. Here, we present MethReg, an R/Bioconductor package that analyzes matched DNA methylation and gene expression data, along with external transcription factor (TF) binding information, to evaluate, prioritize and annotate CpG sites with high regulatory potential. At these CpG sites, TF-target gene associations are often only present in a subset of samples with high (or low) methylation levels, so they can be missed by analyses that use all samples. Using colorectal cancer and Alzheimer's disease datasets, we show MethReg significantly enhances our understanding of the regulatory roles of DNA methylation in complex diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available